Fingerprint
Dive into the research topics of 'A phase II dose-ranging study evaluating the efficacy and safety of the orexin receptor antagonist filorexant (MK-6096) in patients with primary insomnia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically